Inhibition of CD95/CD95L (FAS/FASLG) Signaling with APG101 Prevents Invasion and Enhances Radiation Therapy for Glioblastoma

Blaes, J; Thome, CM; Pfenning, PN; Rubmann, P; Sahm, F; Wick, A; Bunse, T; Schmenger, T; Sykora, J; von Deimling, A; Wiestler, B; Merz, C; Jugold, M; Haberkorn, U; Abdollahi, A; Debus, J; Gieffers, C; Kunz, C; Bendszus, M; Kluge, M; Platten, M; Frick

Lemke, D (reprint author), Univ Hosp Heidelberg, Neuenheimer Feld 400, D-69120 Heidelberg, Germany.

MOLECULAR CANCER RESEARCH, 2018; 16 (5): 767

Abstract

CD95 (Fas/APO-1), a death receptor family member, activity has been linked to tumorigenicity in multiple cancers, including glioblastoma multiforme (G......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索